Relationship of Haptoglobin Phenotypes With Sarcopaenia in Patients With Congestive Heart Failure

Background Systemic inflammation in patients with chronic heart failure (CHF) contributes to age-related muscle loss or sarcopaenia. However, the relationship of plasma haptoglobin (Hp), an acute-phase reactant, with muscle and physical health in CHF is unknown. Methods This study investigated the associations of plasma haptoglobin levels and phenotypes with handgrip strength (HGS), appendicular skeletal muscle index (ASMI) and physical capacity in healthy controls (n=67) and CHF patients (n=61) aged 55-73 years. Results Patients with CHF had higher plasma Hp levels and higher proportions of Hp2-2 phenotype when compared with healthy controls. Plasma Hp2-1 and Hp2-2 levels were negatively associated with HGS and ASMI in healthy controls and CHF (both p,0.05). A negative association of plasma Hp2-2 with gait speed and plasma Hp2-1 with daily steps count was also found in CHF (p,0.05). Patients with Hp2 phenotype showed higher expressions of inflammation and oxidative stress markers, as well as low scores on quality of life parameters. Conclusions Circulating Hp may be a valuable biomarker for assessing muscle health and physical capacity in CHF.

Automated summary

This study found that plasma haptoglobin levels were negatively associated with muscle health and physical capacity in CHF patients. Patients with the Hp2-2 phenotype also showed higher expressions of inflammation and oxidative stress markers, as well as lower scores on quality of life parameters.